UB spinoff company For-Robin moves one step closer to human clinical trials

(University at Buffalo) Scientists from For-Robin Inc., a University at Buffalo biotechnology spinoff, have published new scientific results showing that the company's cancer-fighting antibody can target, penetrate and kill human tumor cells effectively. The findings bring the company closer to human clinical trials.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news